Pascal R. Hammel

35.8k citations
321 papers · 18.2k · 6 hit papers · h-index 66

Impact in

  • Oncology top 0.05%
    • Pancreatic and Hepatic Oncology Research
    • Lung Cancer Research Studies
    • Cancer Genomics and Diagnostics

Papers in

    • Pancreatic and Hepatic Oncology Research 143
    • Lung Cancer Research Studies 22
    • Neuroendocrine Tumor Research Advances 76

Pascal R. Hammel

305 papers receiving 17.6k citations

Pascal R. Hammel's Hit Papers

Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer 2022 · 144 citations
1440+7+14Years since publication50010001.5k

Peers

Pascal R. Hammel
Comparison fields: 5 of 123
  • Oncology 11.7k
  • Cancer Research 2.7k
  • Epidemiology 4.8k
  • Neurology 1.8k
  • Surgery 4.2k
Replace Jason B. Fleming with:
Jason B. Fleming United States
Juan W. Valle United Kingdom
Christopher Lee Wolfgang United States
Volkan N. Adsay United States
Emilio Bajetta Italy
Günter Klöppel Germany
Eileen Mary O'Reilly United States
E. Bergsland United States
Ross Allen Abrams United States
Massimo Falconi Italy
Pascal R. Hammel relative to Jason B. Fleming United States Jason B. Fleming's profile →
Citations per field
00.5×1.6×
Jason B. Fleming · 1×
Citations per year

Countries citing papers authored by Pascal R. Hammel

Since Specialization
Citations

This map shows the geographic impact of Pascal R. Hammel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal R. Hammel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal R. Hammel more than expected).

Fields of papers citing papers by Pascal R. Hammel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal R. Hammel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal R. Hammel. The network helps show where Pascal R. Hammel may publish in the future.

Co-authors

The 25 scholars most cited alongside Pascal R. Hammel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Pascal R. Hammel Line = papers co-authored together Pascal R. Hammel links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 321 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
Hit paper breakdown →
20111965
2
Maintenance Olaparib for Germline BRCA -Mutated Metastatic Pancreatic Cancer
Hit paper breakdown →
20191598
3
Gemcitabine in Combination With Oxaliplatin Compared With Gemcitabine Alone in Locally Advanced or Metastatic Pancreatic Cancer: Results of a GERCOR and GISCAD Phase III Trial
Hit paper breakdown →
2005793
4
Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib
Hit paper breakdown →
2016765
5 2008537
6
nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial
Hit paper breakdown →
2015531
7 2007401
8 2000344
9 2001344
10 2000301
11 2001268
12 2000242
13 2018230
14 1995212
15 2010211
16 2008208
17 2008207
18 2008192
19 2014181
20 1995167

About Pascal R. Hammel

Pascal R. Hammel is a scholar working on Oncology, Epidemiology, Cancer Research, Surgery and Neurology, having authored 321 papers that have together received 18.2k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (143 papers), Neuroendocrine Tumor Research Advances (76 papers), Pancreatitis Pathology and Treatment (51 papers), Cancer Genomics and Diagnostics (27 papers), Neuroblastoma Research and Treatments (25 papers), Lung Cancer Research Studies (22 papers), Gastrointestinal disorders and treatments (17 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (16 papers). The work is most often cited by research in Oncology (11.7k citations), Cancer Research (2.7k citations), Epidemiology (4.8k citations), Neurology (1.8k citations) and Surgery (4.2k citations). Pascal R. Hammel has collaborated with scholars based in France, Belgium and United States. Frequent co-authors include Philippe B Ruszniewski, Alain Sauvanet, Anne Couvelard, Philippe Lévy, Dermot O’Toole, Eric Van Cutsem, Pierre Bernades, Olivia Hentic, Christophe Louvet and Frédérique Maire. Their work appears in journals such as Pancreatology, Pancreas, Annals of Oncology, The American Journal of Gastroenterology and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact